Related references
Note: Only part of the references are listed.Targeting homologous recombination and telomerase in Barrett's adenocarcinoma: impact on telomere maintenance, genomic instability and tumor growth
R. Lu et al.
ONCOGENE (2014)
The role of brevican in glioma: promoting tumor cell motility in vitro and in vivo
Renquan Lu et al.
BMC CANCER (2012)
The HIF-pathway inhibitor NSC-134754 induces metabolic changes and anti-tumour activity while maintaining vascular function
L. C. J. Baker et al.
BRITISH JOURNAL OF CANCER (2012)
The metabolic interactions between tumor cells and tumor-associated stroma (TAS) in prostatic cancer
Alexandra Giatromanolaki et al.
CANCER BIOLOGY & THERAPY (2012)
Systematic, evidence-based discovery of biomarkers at the NCI
John R. Prensner et al.
CLINICAL & EXPERIMENTAL METASTASIS (2012)
Lactate is a mediator of metabolic cooperation between stromal carcinoma associated fibroblasts and glycolytic tumor cells in the tumor microenvironment
Yanique L. Rattigan et al.
EXPERIMENTAL CELL RESEARCH (2012)
Serum Lactate Dehydrogenase Predicts for Overall Survival Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Inhibition of Mammalian Target of Rapamycin
Andrew J. Armstrong et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Synthesis of sulfonamide-containing N-hydroxyindole-2-carboxylates as inhibitors of human lactate dehydrogenase-isoform 5
Carlotta Granchi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Myofibrillogenesis regulator 1 (MR-1) is a novel biomarker and potential therapeutic target for human ovarian cancer
Renquan Lu et al.
BMC CANCER (2011)
Metabolic Imaging: A Link between Lactate Dehydrogenase A, Lactate, and Tumor Phenotype
Inna Serganova et al.
CLINICAL CANCER RESEARCH (2011)
LDH-A influences hypoxia-inducible factor 1α (HIF1 α) and is critical for growth of HT29 colon carcinoma cells in vivo
Stefan Langhammer et al.
TARGETED ONCOLOGY (2011)
Lactate-Dehydrogenase 5 is overexpressed in non-small cell lung cancer and correlates with the expression of the transketolase-like protein 1
Gian Kayser et al.
DIAGNOSTIC PATHOLOGY (2010)
Lactate dehydrogenase 5 expression in melanoma increases with disease progression and is associated with expression of Bcl-XL and Mcl-1, but not Bcl-2 proteins
Liqing Zhuang et al.
MODERN PATHOLOGY (2010)
Pyruvate into lactate and back: From the Warburg effect to symbiotic energy fuel exchange in cancer cells
Olivier Feron
RADIOTHERAPY AND ONCOLOGY (2009)
Lactate dehydrogenase 5 expression in non-Hodgkin B-cell lymphomas is associated with hypoxia regulated proteins
Alexandra Giatromanolaki et al.
LEUKEMIA & LYMPHOMA (2008)
Hypoxia and metabolism - Opinion - A microenvironmental model of carcinogenesis
Robert A. Gatenby et al.
NATURE REVIEWS CANCER (2008)
Incidence and risk factors of central nervous system recurrence in aggressive lymphoma - a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)
V. Boehme et al.
ANNALS OF ONCOLOGY (2007)
Glucose metabolism and cancer
Reuben J. Shaw
CURRENT OPINION IN CELL BIOLOGY (2006)
Lactate dehydrogenase 5 (LDH-5) expression in endometrial cancer relates to the activated VEGF/VEGFR2(KDR) pathway and prognosis
Alexandra Giatromanolaki et al.
GYNECOLOGIC ONCOLOGY (2006)
Cancer's molecular sweet tooth and the Warburg effect
Jung-whan Kim et al.
CANCER RESEARCH (2006)
Lactate dehydrogenase 5 expression in operable colorectal cancer: Strong association with survival and activated vascular endothelial growth factor pathway - A report of the tumour angiogenesis research group
Michael I. Koukourakis et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance
Valeria R. Fantin et al.
CANCER CELL (2006)
Lactate dehydrogenase 5 (LDH5) relates to up-regulated hypoxia inducible factor pathway and metastasis in colorectal cancer
MI Koukourakis et al.
CLINICAL & EXPERIMENTAL METASTASIS (2005)
Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis
MI Koukourakis et al.
BRITISH JOURNAL OF CANCER (2003)
Regulation of hypoxia-inducible factor-1α protein level during hypoxic conditions by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3β pathway in HepG2 cells
D Mottet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis
HS Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival
A Giatromanolaki et al.
BRITISH JOURNAL OF CANCER (2001)
Share Paper
